Alpha Healthcare Acquisition Corp. III (ALPA) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
1177 AVENUE OF THE AMERICAS NEW YORK, NY 10036 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2023 MRQ | 12/31/2022 | 12/31/2021 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 188 | 774 | |||
| Cash and cash equivalents | 188 | 774 | |||
| Receivables | |||||
| Inventory, net of allowances, customer advances and progress billings | |||||
| Inventory | |||||
| Prepaid expense | 98 | 199 | |||
| Other undisclosed current assets | |||||
| Total current assets: | 285 | 973 | |||
| Noncurrent Assets | |||||
| Operating lease, right-of-use asset | |||||
| Property, plant and equipment | |||||
| Intangible assets, net (including goodwill) | |||||
| Goodwill | |||||
| Intangible assets, net (excluding goodwill) | |||||
| Asset, held-in-trust | 156,694 | 154,449 | |||
| Total noncurrent assets: | 156,694 | 154,449 | |||
| TOTAL ASSETS: | 156,979 | 155,422 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,258 | 215 | |||
| Accounts payable | |||||
| Accrued liabilities | 1,258 | 215 | |||
| Deferred compensation liability | |||||
| Due to related parties | ✕ | 32 | 2 | ||
| Other undisclosed current liabilities | 391 | 112 | |||
| Total current liabilities: | 1,682 | 330 | |||
| Noncurrent Liabilities | |||||
| Liabilities, other than long-term debt | |||||
| Deferred income tax liabilities | |||||
| Operating lease, liability | |||||
| Other undisclosed noncurrent liabilities | 5,405 | 5,405 | |||
| Total noncurrent liabilities: | 5,405 | 5,405 | |||
| Total liabilities: | 7,087 | 5,735 | |||
| Equity | |||||
| Equity, attributable to parent, including: | (6,018) | (4,762) | |||
| Preferred stock | |||||
| Common stock | |||||
| Additional paid in capital | |||||
| Accumulated deficit | (6,018) | (4,763) | |||
| Other undisclosed equity, attributable to parent | 0 | 0 | |||
| Other undisclosed equity | 155,910 | 154,449 | |||
| Total equity: | 149,892 | 149,687 | |||
| TOTAL LIABILITIES AND EQUITY: | 156,979 | 155,422 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|
| Revenues | ||||
| Cost of revenue (Cost of Goods and Services Sold) | ||||
| Gross profit: | ||||
| Operating expenses | ||||
| Other undisclosed operating loss | (1,651) | (467) | ||
| Operating loss: | (1,651) | (467) | ||
| Nonoperating income (expense) | 8 | |||
| Investment income, nonoperating | 8 | |||
| Loss from continuing operations before equity method investments, income taxes: | (1,651) | (459) | ||
| Other undisclosed income from continuing operations before income taxes | 2,248 | |||
| Income (loss) from continuing operations before income taxes: | 596 | (459) | ||
| Income tax expense (benefit) | (391) | 96 | ||
| Other undisclosed loss from continuing operations | ||||
| Income (loss) from continuing operations: | 205 | (363) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | (363) | |
| Other undisclosed net income | 33 | |||
| Net income (loss) attributable to parent: | 205 | (329) | ||
| Preferred stock dividends and other adjustments | ||||
| Net income (loss) available to common stockholders, diluted: | 205 | (329) | ||
Comprehensive Income ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|
| Net income (loss): | 205 | (329) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 205 | (329) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.